Volume 54, Issue 2, Pages (August 1998)

Slides:



Advertisements
Similar presentations
Volume 63, Issue 2, Pages (February 2003)
Advertisements

Volume 74, Issue 11, Pages (December 2008)
Volume 58, Issue 4, Pages (October 2000)
Volume 85, Issue 3, Pages (March 2014)
Volume 68, Issue 2, Pages (August 2005)
Volume 79, Issue 1, Pages (January 2011)
Volume 59, Issue 5, Pages (May 2001)
Volume 88, Issue 3, Pages (September 2015)
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule–specific knockout mouse models  Qingqing Wei, Guie Dong,
Renal denervation prevents long-term sequelae of ischemic renal injury
Volume 79, Issue 9, Pages (May 2011)
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Volume 67, Issue 5, Pages (May 2005)
Volume 61, Issue 2, (February 2002)
Functional evidence confirmed by histological localization: overlapping expression of erythropoietin and HIF-2α in interstitial fibroblasts of the renal.
Volume 74, Issue 11, Pages (December 2008)
Volume 64, Issue 2, Pages (August 2003)
Volume 61, Issue 5, Pages (May 2002)
Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats  Julie Chao, Jenny J. Zhang, Kuei-Fu Lin,
Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil  Q. Sun, Z-H. Liu, Z. Cheng, J. Chen,
Genistein protects the kidney from cisplatin-induced injury
Volume 75, Issue 2, Pages (January 2009)
Volume 63, Issue 4, Pages (April 2003)
Volume 79, Issue 1, Pages (January 2011)
Volume 70, Issue 2, Pages (July 2006)
Volume 62, Issue 3, Pages (September 2002)
Vikas Chander, PhD, Kanwaljit Chopra, PhD  Journal of Vascular Surgery 
Volume 54, Issue 6, Pages (January 1998)
Hiroyuki Yanagisawa, Nobuyuki Yamazaki, Gen Sato, Osamu Wada 
Karl A. Nath, Anthony J. Croatt, Jill J. Haggard, Joseph P. Grande 
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
Volume 77, Issue 9, Pages (May 2010)
Volume 54, Issue 3, Pages (September 1998)
Gilbert R. Kinsey, Liping Huang, Amy L. Vergis, Li Li, Mark D. Okusa 
Volume 80, Issue 12, Pages (December 2011)
Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney  Kent Doi, Yoshifumi Suzuki, Akihide Nakao,
Ischemic and non-ischemic acute kidney injury cause hepatic damage
Volume 61, Issue 3, Pages (March 2002)
Volume 62, Issue 2, Pages (August 2002)
Volume 60, Issue 6, Pages (December 2001)
Volume 62, Issue 2, Pages (August 2002)
Volume 57, Issue 3, Pages (March 2000)
Volume 54, Issue 3, Pages (September 1998)
Volume 73, Issue 12, Pages (June 2008)
Volume 65, Issue 3, Pages (March 2004)
Volume 63, Issue 2, Pages (February 2003)
Resistance to ischemic acute renal failure in the Brown Norway rat: A new model to study cytoprotection  David P. Basile, Deborah Donohoe, X.I.A. Cao,
Volume 56, Issue 3, Pages (September 1999)
Volume 63, Issue 5, Pages (May 2003)
Volume 66, Issue 4, Pages (October 2004)
Volume 76, Issue 7, Pages (October 2009)
Volume 75, Issue 5, Pages (March 2009)
Volume 79, Issue 2, Pages (January 2011)
Volume 74, Issue 1, Pages (July 2008)
Volume 74, Issue 11, Pages (December 2008)
Volume 57, Issue 1, Pages (January 2000)
Volume 60, Issue 6, Pages (December 2001)
Volume 56, Issue 5, Pages (November 1999)
Volume 67, Issue 4, Pages (April 2005)
The treatment of acute interstitial nephritis: More data at last
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Inflammatory cells in ischemic acute renal failure
Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure  D.W. Johnson, B. Pat, D.A. Vesey, Z.
Volume 58, Issue 5, Pages (November 2000)
Volume 53, Issue 6, Pages (June 1998)
The Case | Peculiar fibrous nodules in a renal transplant biopsy
Volume 60, Issue 3, Pages (September 2001)
Volume 65, Issue 3, Pages (March 2004)
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Presentation transcript:

Volume 54, Issue 2, Pages 590-602 (August 1998) ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation  Duska Dragun, Stefan G. Tullius, Joon Keun Park, Christian Maasch, Ivo Lukitsch, Andrea Lippoldt, Volkmar Groß, Friedrich C. Luft, Hermann Haller  Kidney International  Volume 54, Issue 2, Pages 590-602 (August 1998) DOI: 10.1046/j.1523-1755.1998.00026.x Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 Experimental protocol. Three autotransplanted groups were studied: saline-treated rats, antisense oligodesoxynucleotide (ODN)-treated rats, and reverse ODN-treated rats. Their renal function and histology was also compared to uninephrectomized, nonautotransplanted, sham-operated, control rats. The time course is outlined. Kidney International 1998 54, 590-602DOI: (10.1046/j.1523-1755.1998.00026.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 2 Effect of saline treatment, antisense ODN treatment, and reverse ODN treatment on ICAM-1 expression in transplanted rat kidneys. Upper panel shows immunohistochemical staining (representative of 30 photomicrographs) for ICAM-1 in sham-operated animals (A), autotransplanted animals with saline treatment (B), antisense ODN treatment (C), and reverse ODN treatment (D). (E) The densitometric data from these sections (N = 30, *P < 0.05). Ischemia-reperfusion injury induced a marked increase in ICAM-1 expression in the glomeruli, along the endothelial cell lining of the blood vessels, and in the peritubular area. Antisense ODN prevented the ischemia-induced increase in ICAM-1 expression both in the glomeruli and in the vasculature, while reverse ODN had no effect. Kidney International 1998 54, 590-602DOI: (10.1046/j.1523-1755.1998.00026.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 2 Effect of saline treatment, antisense ODN treatment, and reverse ODN treatment on ICAM-1 expression in transplanted rat kidneys. Upper panel shows immunohistochemical staining (representative of 30 photomicrographs) for ICAM-1 in sham-operated animals (A), autotransplanted animals with saline treatment (B), antisense ODN treatment (C), and reverse ODN treatment (D). (E) The densitometric data from these sections (N = 30, *P < 0.05). Ischemia-reperfusion injury induced a marked increase in ICAM-1 expression in the glomeruli, along the endothelial cell lining of the blood vessels, and in the peritubular area. Antisense ODN prevented the ischemia-induced increase in ICAM-1 expression both in the glomeruli and in the vasculature, while reverse ODN had no effect. Kidney International 1998 54, 590-602DOI: (10.1046/j.1523-1755.1998.00026.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 3 (A) Western blot for ICAM-1 expression in the kidneys (representative experiment of 12 kidneys in each group) of sham operated animals, autotransplanted animals with saline treatment, antisense ODN treatment, and reverse ODN treatment. (B) Densitometric data from these Western blots (N = 4 in each group). Ischemia and reperfusion induced a marked increase in ICAM-1 expression both in the renal cortex and in the renal medulla. Treatment with antisense ODN prevented the ischemia-induced increase in ICAM-1 expression. *P < 0.01, both in the vasculature and in the peritubular area. Reverse ODN had no effect. Kidney International 1998 54, 590-602DOI: (10.1046/j.1523-1755.1998.00026.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 4 Effect of antisense and reverse ODN on glomerular filtration rate (GFR). Inulin clearance 24hours after transplantation (Tx) is shown. Saline-treated (N = 4) and reverse ODN-treated animals (N = 6) were anuric. Antisense ODN treatment prevented the ischemia-induced acute renal failure; inulin clearance of these animals (N = 6) was not different from sham-operated (N = 4) renal function control animals. Symbols are: (▪) antisense ODN + Tx; (▩) reverse ODN + Tx; (□) sham operated + 0.9% NaCl; (▩) 0.9% NaCl + Tx. Kidney International 1998 54, 590-602DOI: (10.1046/j.1523-1755.1998.00026.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 5 Serum creatinine concentrations before and after transplantation (Tx). Saline-treated animals showed a significant increase in serum creatinine concentrations after 12 and 24hours. Antisense ODN treatment prevented the ischemia-induced increase in serum creatinine concentrations 12 (*P < 0.01) and 24hours after Tx (#P < 0.001). Reverse ODN had no effect. Symbols are: (•) antisense + Tx; (□) reverse + Tx; (⋄) NaCl + Tx; (▵) sham operated + NaCl. Kidney International 1998 54, 590-602DOI: (10.1046/j.1523-1755.1998.00026.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 6 (Opposite page, top) Immunohistochemical staining (representative of 30 photomicrographs) of transplanted kidneys for neutrophils in sham-operated animals (A), autotransplanted animals with saline treatment (B), antisense ODN treatment (C), and reverse ODN treatment (D). The number of granulocyte infiltrates in the glomeruli (E) and the perivascular area (F) qualitatively expressed as no infiltrates (□), 1 to 4 infiltrates (▨), or ≥ 5 infiltrates (▪) from these immunohistochemical sections (glomeruli and vessels counted N > 50; *P < 0.05). Antisense ODN treatment decreased neutrophil infiltration. Kidney International 1998 54, 590-602DOI: (10.1046/j.1523-1755.1998.00026.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 7 (Opposite page, bottom) Immunohistochemical staining (representative of 30 photomicrographs) of transplanted kidneys for monocytes in sham-operated animals (A), autotransplanted animals with saline treatment (B), antisense ODN treatment (C), and reverse ODN treatment (D). The number of moncyte infiltrates in the glomeruli (E) and the perivascular area (F) are qualitatively expressed as no infiltrates (□), 1 to 4 infiltrates (▨), or ≥ 5 infiltrates (▪) from these immunohistochemical sections (glomeruli and vessels counted N > 50; *P < 0.05). Antisense ODN decreased monocyte infiltration. Kidney International 1998 54, 590-602DOI: (10.1046/j.1523-1755.1998.00026.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 8 Immunohistochemical staining (representative of 30 photomicrographs) of transplanted kidneys for MHC II expression in sham-operated animals (A), autotransplanted animals with saline treatment (B), antisense ODN treatment (C), and reverse ODN treatment (D). Antisense ODN prevented ischemia reperfusion induced increase in MHC II expression. Kidney International 1998 54, 590-602DOI: (10.1046/j.1523-1755.1998.00026.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 9 Hematoxylin and eosin-stained, thin sections of fixed, paraffin-embedded, rat kidneys (representative of 30 sections) in sham-operated animals (A), autotransplanted animals with saline treatment (B), antisense ODN treatment (C), and reverse ODN treatment (D). Inflammatory infiltrate and tubular necrosis manifest by swollen, vacuolated, proximal tubular cells with pyknotic nuclei and necrotic cells was diminished by antisense ODN treatment. Kidney International 1998 54, 590-602DOI: (10.1046/j.1523-1755.1998.00026.x) Copyright © 1998 International Society of Nephrology Terms and Conditions